Learn about Haloperidol, a potent antipsychotic medication (ATC N05) used to manage severe psychotic disorders, Tourette's syndrome, and acute agitation. Understand its mechanism, uses, and important safety information.
Browse our catalog for available pharmaceutical products and competitive pricing.
Haloperidol is a potent antipsychotic medication belonging to the butyrophenone class. It is classified as a first-generation, or typical, antipsychotic. Primarily used in the management of severe mental and behavioral disorders, Haloperidol helps to alleviate symptoms such as hallucinations, delusions, and disorganized thought processes by affecting certain chemical messengers in the brain. Its efficacy in controlling acute psychotic episodes and chronic conditions has made it a cornerstone in psychiatric treatment for decades.
As an antipsychotic, Haloperidol falls under the ATC code N05, which designates psycholeptics, specifically antipsychotics. It is known for its strong dopaminergic blocking activity, which is central to its therapeutic effects. Available in various formulations, including oral tablets, oral solution, and injectable forms, Haloperidol offers flexibility in administration to suit different clinical needs, from acute emergency situations to long-term maintenance therapy.
The primary mechanism of action of Haloperidol involves the potent antagonism of dopamine D2 receptors in the brain. By blocking these receptors, particularly in the mesolimbic pathway, Haloperidol reduces excessive dopaminergic activity, which is believed to contribute to the positive symptoms of psychosis, such as hallucinations and delusions. This receptor blockade helps to stabilize mood and thought processes in affected individuals.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Acute Psychosis/Agitation | 2-5 mg | Every 4-8 hours as needed | Oral, Intramuscular (IM) |
| Chronic Schizophrenia | 0.5-20 mg/day | Once or twice daily | Oral |
| Tourette's Syndrome | 0.5-5 mg/day | Once or twice daily | Oral |
Note: Dosages for Haloperidol are highly individualized and must be determined by a healthcare professional based on the patient's condition, response to treatment, and tolerability.
Haloperidol is contraindicated in patients with Parkinson's disease, severe central nervous system (CNS) depression, comatose states, or known hypersensitivity to the drug. Caution should be exercised in patients with pre-existing cardiac conditions, epilepsy, or significant liver or kidney impairment. Abrupt discontinuation of Haloperidol can lead to withdrawal symptoms or a relapse of psychotic symptoms, hence it should always be tapered under medical supervision.
This article provides general information about Haloperidol and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis, treatment, and before making any decisions related to your health or medication. Do not start, stop, or change any medication without medical supervision.